Fox Chase Cancer Center Welcomes Dr. Anthony Stack

Stack 1200
Anthony Stack, DO, has joined Fox Chase Cancer Center as an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies.

PHILADELPHIA (September 24, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Anthony Stack, DO, as an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies

Stack is joining the Fox Chase team following his completion of the Fox Chase Hematology/Oncology Fellowship Training Program, where he gained extensive experience in treating complex hematologic malignancies. Prior to his fellowship, Stack completed Temple University Hospital’s Internal Medicine Residency Program. 

Stack earned his medical degree from the Lake Erie College of Osteopathic Medicine in Bradenton, Florida. Prior to that he graduated from the University of Missouri with a bachelor’s degree in nutritional sciences. 

Throughout his career, Stack has made substantial contributions to the field of oncology with numerous peer-reviewed publications and international research presentations. His research interests span critical areas such as lymphoma, multiple myeloma, and chimeric antigen receptor (CAR) T-cell therapy. 

In recognition of his academic achievements, Stack has received various accolades, including the Dedication to Primary Care Award from the Lake Erie College of Osteopathic Medicine, the Resident Research Career Development Award from Temple University Hospital, and the Young Investigator Award from Fox Chase. 

Stack has served on various committees, including the Cancer Committee at Temple University Hospital and the Research Review Committee at Fox Chase. He is also an active member of the American Society of Hematology, the American Society of Clinical Oncology, and the European Hematology Association.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427